Wedbush analyst Laura Chico lowered the firm’s price target on Biogen (BIIB) to $135 from $166 and keeps a Neutral rating on the shares. The ...

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

Zoetis stock plunged Thursday after the company's 2025 guidance missed forecasts, though fourth-quarter metrics beat.